These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 25820783)

  • 1. Gaucher-Associated Parkinsonism.
    Li Y; Li P; Liang H; Zhao Z; Hashimoto M; Wei J
    Cell Mol Neurobiol; 2015 Aug; 35(6):755-61. PubMed ID: 25820783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [GBA mutations and Parkinson's disease].
    Wang DX; Xie JX; Song N
    Sheng Li Xue Bao; 2018 Jun; 70(3):294-300. PubMed ID: 29926071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-talks among GBA mutations, glucocerebrosidase, and α-synuclein in GBA-associated Parkinson's disease and their targeted therapeutic approaches: a comprehensive review.
    Behl T; Kaur G; Fratila O; Buhas C; Judea-Pusta CT; Negrut N; Bustea C; Bungau S
    Transl Neurodegener; 2021 Jan; 10(1):4. PubMed ID: 33446243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the link between glucocerebrosidase mutations and parkinsonism.
    Westbroek W; Gustafson AM; Sidransky E
    Trends Mol Med; 2011 Sep; 17(9):485-93. PubMed ID: 21723784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The link between the GBA gene and parkinsonism.
    Sidransky E; Lopez G
    Lancet Neurol; 2012 Nov; 11(11):986-98. PubMed ID: 23079555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutation.
    Fishbein I; Kuo YM; Giasson BI; Nussbaum RL
    Brain; 2014 Dec; 137(Pt 12):3235-47. PubMed ID: 25351739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocerebrosidase and parkinsonism: lessons to learn.
    Marković I; Kresojević N; Kostić VS
    J Neurol; 2016 May; 263(5):1033-1044. PubMed ID: 26995357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocerebrosidase deficiency promotes release of α-synuclein fibrils from cultured neurons.
    Gegg ME; Verona G; Schapira AHV
    Hum Mol Genet; 2020 Jun; 29(10):1716-1728. PubMed ID: 32391886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viable neuronopathic Gaucher disease model in Medaka (Oryzias latipes) displays axonal accumulation of alpha-synuclein.
    Uemura N; Koike M; Ansai S; Kinoshita M; Ishikawa-Fujiwara T; Matsui H; Naruse K; Sakamoto N; Uchiyama Y; Todo T; Takeda S; Yamakado H; Takahashi R
    PLoS Genet; 2015 Apr; 11(4):e1005065. PubMed ID: 25835295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between ß-glucocerebrosidase mutations and parkinsonism.
    Swan M; Saunders-Pullman R
    Curr Neurol Neurosci Rep; 2013 Aug; 13(8):368. PubMed ID: 23812893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between mutations in the lysosomal protein glucocerebrosidase and parkinsonism.
    DePaolo J; Goker-Alpan O; Samaddar T; Lopez G; Sidransky E
    Mov Disord; 2009 Aug; 24(11):1571-8. PubMed ID: 19425057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-synuclein interacts with Glucocerebrosidase providing a molecular link between Parkinson and Gaucher diseases.
    Yap TL; Gruschus JM; Velayati A; Westbroek W; Goldin E; Moaven N; Sidransky E; Lee JC
    J Biol Chem; 2011 Aug; 286(32):28080-8. PubMed ID: 21653695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains.
    Gegg ME; Burke D; Heales SJ; Cooper JM; Hardy J; Wood NW; Schapira AH
    Ann Neurol; 2012 Sep; 72(3):455-63. PubMed ID: 23034917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocerebrosidase haploinsufficiency in A53T α-synuclein mice impacts disease onset and course.
    Tayebi N; Parisiadou L; Berhe B; Gonzalez AN; Serra-Vinardell J; Tamargo RJ; Maniwang E; Sorrentino Z; Fujiwara H; Grey RJ; Hassan S; Blech-Hermoni YN; Chen C; McGlinchey R; Makariou-Pikis C; Brooks M; Ginns EI; Ory DS; Giasson BI; Sidransky E
    Mol Genet Metab; 2017 Dec; 122(4):198-208. PubMed ID: 29173981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between lysosomal protein glucocerebrosidase and Parkinson's disease.
    Kong B; Yang T; Gu JW; Kuang YQ; Cheng L; Yang WT; Yang XK; Xia X; Cheng JM; Ma Y; Zhang JH; Yu SX
    Eur Rev Med Pharmacol Sci; 2013 Jan; 17(2):143-51. PubMed ID: 23377801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of Gaucher Disease Mutations in Parkinson Disease.
    Vilageliu L; Grinberg D
    Curr Protein Pept Sci; 2017; 18(7):758-764. PubMed ID: 26965692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucosylsphingosine Promotes α-Synuclein Pathology in Mutant GBA-Associated Parkinson's Disease.
    Taguchi YV; Liu J; Ruan J; Pacheco J; Zhang X; Abbasi J; Keutzer J; Mistry PK; Chandra SS
    J Neurosci; 2017 Oct; 37(40):9617-9631. PubMed ID: 28847804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysosomal functions and dysfunctions: Molecular and cellular mechanisms underlying Gaucher disease and its association with Parkinson disease.
    Horowitz M; Braunstein H; Zimran A; Revel-Vilk S; Goker-Alpan O
    Adv Drug Deliv Rev; 2022 Aug; 187():114402. PubMed ID: 35764179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significance of GBA for Parkinson's disease.
    Brockmann K; Berg D
    J Inherit Metab Dis; 2014 Jul; 37(4):643-8. PubMed ID: 24894157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocerebrosidase enzyme activity in GBA mutation Parkinson's disease.
    Ortega RA; Torres PA; Swan M; Nichols W; Boschung S; Raymond D; Barrett MJ; Johannes BA; Severt L; Shanker V; Hunt AL; Bressman S; Pastores GM; Saunders-Pullman R
    J Clin Neurosci; 2016 Jun; 28():185-6. PubMed ID: 26857292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.